Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$89.70 -1.0%	$82.44	$58.50 ▼ $98.43	$115.62B	0.62	8.53 million shs	5.65 million shs
HAE Haemonetics	$66.34 -1.3%	$59.12	$47.31 ▼ $87.32	$3.05B	0.56	970,442 shs	921,817 shs
SRTS Sensus Healthcare	$2.84 -0.4%	$3.84	$2.66 ▼ $5.92	$46.92M	1.09	104,541 shs	80,193 shs

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	-1.11%	-1.37%	+9.23%	+11.33%	+41.04%
HAE Haemonetics	-1.53%	-0.82%	+11.71%	+2.52%	-3.55%
SRTS Sensus Healthcare	-0.35%	-11.25%	-28.64%	-35.60%	-39.83%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$89.70 -1.0%	$82.44	$58.50 ▼ $98.43	$115.62B	0.62	8.53 million shs	5.65 million shs
HAE Haemonetics	$66.34 -1.3%	$59.12	$47.31 ▼ $87.32	$3.05B	0.56	970,442 shs	921,817 shs
SRTS Sensus Healthcare	$2.84 -0.4%	$3.84	$2.66 ▼ $5.92	$46.92M	1.09	104,541 shs	80,193 shs

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	-1.11%	-1.37%	+9.23%	+11.33%	+41.04%
HAE Haemonetics	-1.53%	-0.82%	+11.71%	+2.52%	-3.55%
SRTS Sensus Healthcare	-0.35%	-11.25%	-28.64%	-35.60%	-39.83%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVS CVS Health	2.85	Moderate Buy	$99.68	11.13% Upside
HAE Haemonetics	2.64	Moderate Buy	$77.11	16.23% Upside
SRTS Sensus Healthcare	2.57	Moderate Buy	$6.88	142.08% Upside

Current Analyst Ratings Breakdown

Latest SRTS, HAE, and CVS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/1/2026	CVS CVS Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$113.00
6/1/2026	CVS CVS Health	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$102.00 ➝ $108.00
5/28/2026	HAE Haemonetics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$64.00 ➝ $70.00
5/26/2026	CVS CVS Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$101.00 ➝ $106.00
5/22/2026	HAE Haemonetics	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$72.00 ➝ $80.00
5/21/2026	HAE Haemonetics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
5/20/2026	CVS CVS Health	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$102.00 ➝ $110.00
5/14/2026	CVS CVS Health	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$90.00 ➝ $104.00
5/14/2026	CVS CVS Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$93.00 ➝ $106.00
5/12/2026	HAE Haemonetics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
5/12/2026	CVS CVS Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$101.00 ➝ $111.00

(Data available from 6/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVS CVS Health	$407.91B	0.28	$14.73 per share	6.09	$59.38 per share	1.51
HAE Haemonetics	$1.33B	2.26	$7.48 per share	8.87	$17.14 per share	3.87
SRTS Sensus Healthcare	$27.48M	1.70	N/A	N/A	$2.93 per share	0.97

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVS CVS Health	$1.77B	$2.27	39.51	10.74	0.89	0.72%	11.88%	3.54%	7/30/2026 (Estimated)
HAE Haemonetics	$97.31M	$2.02	32.84	11.56	1.35	7.29%	27.30%	9.59%	8/6/2026 (Estimated)
SRTS Sensus Healthcare	-$7.72M	-$0.47	N/A	N/A	N/A	-34.50%	-15.79%	-14.02%	8/6/2026 (Estimated)

Latest SRTS, HAE, and CVS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2026	Q4 2026	HAE Haemonetics	$1.28	$1.29	+$0.01	-$0.44	$336.83 million	$346.35 million
5/7/2026	Q1 2026	SRTS Sensus Healthcare	-$0.1250	-$0.16	-$0.0350	-$0.16	$5.32 million	$3.39 million
5/6/2026	Q1 2026	CVS CVS Health	$2.21	$2.57	+$0.36	$2.30	$94.99 billion	$100.43 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVS CVS Health	$2.66	2.97%	+5.87%	117.18%	4 Years
HAE Haemonetics	N/A	N/A	N/A	N/A	N/A
SRTS Sensus Healthcare	N/A	N/A	N/A	N/A	N/A

Latest SRTS, HAE, and CVS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/18/2026	CVS CVS Health	quarterly	$0.6650	3.37%	4/23/2026	4/23/2026	5/4/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVS CVS Health	0.78	0.87	0.66
HAE Haemonetics	1.53	2.95	1.87
SRTS Sensus Healthcare	N/A	7.27	4.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVS CVS Health	80.66%
HAE Haemonetics	99.67%
SRTS Sensus Healthcare	25.30%

Insider Ownership

Company	Insider Ownership
CVS CVS Health	0.85%
HAE Haemonetics	1.84%
SRTS Sensus Healthcare	10.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVS CVS Health	300,000	1.28 billion	1.27 billion	Optionable
HAE Haemonetics	3,009	45.45 million	44.61 million	Optionable
SRTS Sensus Healthcare	40	16.46 million	14.78 million	Optionable

SRTS, HAE, and CVS Headlines

Recent News About These Companies

Sensus Healthcare Shareholders Back Board, Pay, and Auditor

June 2 at 8:50 AM | tipranks.com

Financial Comparison: Sensus Healthcare (NASDAQ:SRTS) and Spectral AI (NASDAQ:MDAI)

May 30, 2026 | americanbankingnews.com

How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes

May 20, 2026 | finance.yahoo.com

Sensus Healthcare Balances Weak Quarter With Growth Catalysts

May 20, 2026 | tipranks.com

Sensus Healthcare (NASDAQ:SRTS) Lowered to "Strong Sell" Rating by Wall Street Zen

May 9, 2026 | marketbeat.com

Sensus outlines full year profitability goal for 2026 as new CPT codes take effect

May 8, 2026 | seekingalpha.com

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2026 Earnings Call Transcript

May 8, 2026 | insidermonkey.com

Sensus Healthcare Q1 Earnings Call Highlights

May 8, 2026 | marketbeat.com

Sensus Healthcare Charts Recovery Path Amid Revenue Drop

May 8, 2026 | tipranks.com

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS

May 8, 2026 | marketbeat.com

Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology

May 8, 2026 | businesswire.com

Sensus (SRTS) Q1 2026 Earnings Transcript

May 8, 2026 | finance.yahoo.com

Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights

May 7, 2026 | businesswire.com

Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

April 23, 2026 | businesswire.com

Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract

March 27, 2026 | businesswire.com

Why The Sensus Healthcare (SRTS) Story Is Shifting As Targets Diverge On 2026 Expectations

March 12, 2026 | finance.yahoo.com

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base

February 26, 2026 | finance.yahoo.com

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base

February 26, 2026 | businesswire.com

Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology

February 18, 2026 | finance.yahoo.com

Sensus Healthcare, Inc. (NASDAQ:SRTS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

February 15, 2026 | finance.yahoo.com

Sensus Healthcare Bets on 2026 Reimbursement Rebound

February 13, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SRTS, HAE, and CVS Company Descriptions

CVS Health NYSE:CVS

$89.70 -0.92 (-1.02%)

Closing price 06/2/2026 03:59 PM Eastern

Extended Trading

$89.58 -0.12 (-0.13%)

As of 08:01 AM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Haemonetics NYSE:HAE

$66.34 -0.88 (-1.31%)

Closing price 06/2/2026 03:59 PM Eastern

Extended Trading

$66.48 +0.14 (+0.21%)

As of 06:53 AM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Sensus Healthcare NASDAQ:SRTS

$2.84 -0.01 (-0.35%)

Closing price 06/2/2026 04:00 PM Eastern

Extended Trading

$2.90 +0.06 (+2.11%)

As of 07:00 AM Eastern

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SRTS, HAE, and CVS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SRTS, HAE, and CVS Earnings

Compare Dividends

Latest SRTS, HAE, and CVS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SRTS, HAE, and CVS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SRTS, HAE, and CVS Company Descriptions

CVS Health NYSE:CVS

Haemonetics NYSE:HAE

Sensus Healthcare NASDAQ:SRTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SRTS, HAE, and CVS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SRTS, HAE, and CVS Earnings

Compare Dividends

Latest SRTS, HAE, and CVS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SRTS, HAE, and CVS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SRTS, HAE, and CVS Company Descriptions

CVS Health NYSE:CVS

Haemonetics NYSE:HAE

Sensus Healthcare NASDAQ:SRTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools